Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,276.00    20.00 (1.59%)
Bid:
1,284.00
Ask:
1,292.00
Spread: 8.00 (0.623%)
Market Cap: £584.74m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract win

29 Oct 2013 07:00

RNS Number : 5812R
Cohort PLC
29 October 2013
 



29 October 2013

 

Cohort plc

 

("Cohort" or "the Group")

 

SEA Awarded £5m contract to support the development of the next generation Submarine Communications Buoy

 

Cohort, the independent technology group, is pleased to announce that its subsidiary SEA has been awarded a contract by Babcock Marine for the second phase of the Submarine Communications Buoy technology demonstrator. The value of the contract is approximately £5 million, the bulk of which will be delivered over the next 24 months.

 

SEA is a partner to Babcock Marine, the UK's leading naval support business and a subsidiary of Babcock International Group plc, in this programme which aims to develop and prove a new generation communications buoy for use on UK submarines. The award follows successful simulation and testing of the technology in collaboration with Babcock during Phase One of the development process. SEA will now provide specialist modelling support and manage the trials programme as well as developing and supplying the inboard electronics units.

 

Cohort will be releasing its half year results for the six months ended 31 October 2013 on Monday 16th December 2013.

 

Andrew Thomis, Chief Executive of Cohort plc said:

 

"This is a really pleasing win for SEA and another endorsement of our world-class expertise in both submarine communications and computer simulation in the marine environment.

 

"This and other recent orders have improved our revenue visibility for the current year and going into 2014/15. Beyond these successes we continue to see a good pipeline of both domestic and export opportunities, though the timing of the latter is always hard to predict"

 

Ends

For further information, please contact

 

Cohort plc

 

Andrew Thomis, Chief Executive

Simon Walther, Finance Director

 

+44 (0)118 909 0390

 

Investec

Keith Anderson, Daniel Adams

 

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins, Ben Griffiths

+44 (0)20 3128 8100

cohort@mhpc.com

 

 

Cohort plc (www.cohortplc.com) (@Cohortplc)

 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through three market-facing subsidiary companies:

Ÿ MASS (www.mass.co.uk) - a specialist systems house with considerable experience in the defence market and a focus on information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

 

Ÿ SCS (www.scs-ltd.co.uk) - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

 

Ÿ SEA (www.sea.co.uk) - an advanced surveillance systems and software house with hardware development capability operating in the defence, space and transport market sectors. Acquired by Cohort in October 2007.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire and Somerset.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTNKFDNOBDDAKB
Date   Source Headline
5th Dec 20237:00 amRNSContract Win
1st Dec 20239:55 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSNotice of Half Year Results
6th Nov 202310:21 amRNSHolding(s) in Company
3rd Nov 202310:35 amRNSHolding(s) in Company
1st Nov 202310:03 amRNSTotal Voting Rights
19th Oct 20237:00 amRNSSHARES/AJ BELL IN-PERSON INVESTOR EVENT NEXT WEEK
16th Oct 20237:00 amRNSShares/AJ Bell Live Investor Event, October 25
13th Oct 20234:03 pmRNSDirector/PDMR Shareholding
6th Oct 20233:48 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:09 pmRNSBlock listing six monthly return
2nd Oct 20231:04 pmRNSTotal Voting Rights
29th Sep 202310:18 amRNSDirector/PDMR Shareholding
26th Sep 20235:00 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Statement & First Quarter Update
21st Sep 20233:45 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSTotal Voting Rights
30th Aug 20232:34 pmRNSDirector/PDMR Shareholding
24th Aug 20233:26 pmRNSBlock listing six monthly return
24th Aug 20232:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Aug 20237:00 amRNSContract Win
11th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20231:39 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTotal Voting Rights
2nd Jun 20238:02 amRNSTotal Voting Rights
30th May 20238:00 amRNSContract Win
26th May 20239:56 amRNSEBT Purchase of Shares
25th May 20237:00 amRNSFull Year Trading Update
22nd May 20233:15 pmRNSEBT Purchase of Shares
15th May 20233:27 pmRNSEBT Purchase of Shares
10th May 20235:56 pmRNSEBT Purchase of Shares
9th May 202311:41 amRNSHolding(s) in Company
9th May 20239:16 amRNSContract Win
2nd May 20232:47 pmRNSDirector/PDMR Shareholding
2nd May 20232:42 pmRNSEBT Purchase of Shares
2nd May 20232:36 pmRNSTotal Voting Rights
27th Apr 20239:00 amRNSContract Announcement
5th Apr 20237:00 amRNSContract Announcement
3rd Apr 202310:30 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSBlock Listing Six Monthly Return
23rd Mar 20237:00 amRNSMASS contracted to supply EW Operation Support
22nd Mar 20237:00 amRNSChess awarded contract extension
14th Mar 202310:30 amRNSDirector/PDMR Shareholding
1st Mar 202312:38 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNSRecording of Investor Presentation
24th Feb 20231:25 pmRNSBlock listing Interim Review
17th Feb 202310:13 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.